{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:53:20Z","timestamp":1794725600070,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["PR-ST-0614-00008_18]"],"award-info":[{"award-number":["PR-ST-0614-00008_18]"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Sporadic Creutzfeldt\u2013Jakob Disease (sCJD) is the commonest human prion disease, with a median age of onset of 68\u00a0years. We characterise the clinical, investigation, and neuropathological features in young individuals with sCJD using data from UK national CJD surveillance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Referrals between 2011 and 2021 were examined, with definite (post-mortem confirmed) or probable sCJD cases included. Clinical features, MRI, EEG, CSF RT-QuIC, 14-3-3, <jats:italic>PRNP<\/jats:italic> sequencing and neuropathological findings were examined. We compared younger (\u2264\u200950 years age of onset) with older individuals. Records of Non-sCJD referrals were also reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>46 (4%) young individuals were identified (age at onset 25\u201350) from 1178 cases. 15 (33%) were autopsy confirmed. Psychiatric disturbance (37% vs 22%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and headache (11% vs 3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.01) at presentation, and longer disease duration (by 1.45\u00a0months, 95% CI 0.43\u20132.79, logrank <jats:italic>p<\/jats:italic>\u2009=\u20090.007) were commoner. CSF RT-QuIC showed lower sensitivity (82% vs 93%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02). There was no difference in sensitivity of MR brain or CSF 14-3-3. There were no significant co-pathologies in autopsy-confirmed cases. For non-sCJD referrals, 41 cases were of other CJD subtypes, and 7 non-prion diagnoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Young-onset sCJD is more likely to present with neuropsychiatric symptoms and headache, longer disease duration, and lower sensitivity of RT-QuIC. These findings may be driven by the underlying molecular subtypes. Our results guide the evaluation of younger individuals presenting with rapidly progressive cognitive, neuropsychiatric, and motor decline, and emphasise the need for additional vigilance for atypical features by clinicians and CJD surveillance programmes worldwide.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-022-11467-3","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T12:02:51Z","timestamp":1667649771000},"page":"1036-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sporadic Creutzfeldt\u2013Jakob Disease in the young (50 and below): 10-year review of United Kingdom surveillance"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-2666","authenticated-orcid":false,"given":"Johnny","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-8403","authenticated-orcid":false,"given":"John","family":"Centola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-4346","authenticated-orcid":false,"given":"Hatice","family":"Kurudzhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-4643","authenticated-orcid":false,"given":"Neil","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-2684","authenticated-orcid":false,"given":"Janet","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Leitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-6751","authenticated-orcid":false,"given":"Alison","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-046X","authenticated-orcid":false,"given":"David","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4789-7401","authenticated-orcid":false,"given":"Marcelo","family":"Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-5132","authenticated-orcid":false,"given":"Colin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4276-639X","authenticated-orcid":false,"given":"Suvankar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"key":"11467_CR1","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","volume":"20","author":"L Uttley","year":"2020","unstructured":"Uttley L, Carroll C, Wong R et al (2020) Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis 20:e2\u2013e10. https:\/\/doi.org\/10.1016\/S1473-3099(19)30615-2","journal-title":"Lancet Infect Dis"},{"key":"11467_CR2","doi-asserted-by":"publisher","first-page":"e2146319","DOI":"10.1001\/JAMANETWORKOPEN.2021.46319","volume":"5","author":"N Watson","year":"2022","unstructured":"Watson N, Hermann P, Ladogana A et al (2022) Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease. JAMA Netw Open 5:e2146319\u2013e2146319. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2021.46319","journal-title":"JAMA Netw Open"},{"key":"11467_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM11020207","volume":"11","author":"D Ritchie","year":"2021","unstructured":"Ritchie D, Barria M (2021) Prion diseases: a unique transmissible agent or a model for neurodegenerative diseases? Biomolecules 11:1\u201323. https:\/\/doi.org\/10.3390\/BIOM11020207","journal-title":"Biomolecules"},{"key":"11467_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-32-9449-3_14","author":"SB Rufai","year":"2019","unstructured":"Rufai SB, Gupta A, Singh S (2019) Prion diseases: a concern for mankind. Pathogen Drug Resist Hum Pathogens Mech Novel Approach. https:\/\/doi.org\/10.1007\/978-981-32-9449-3_14","journal-title":"Pathogen Drug Resist Hum Pathogens Mech Novel Approach"},{"key":"11467_CR5","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1073\/PNAS.96.26.15137","volume":"96","author":"MR Scott","year":"1999","unstructured":"Scott MR, Will R, Ironside J et al (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci 96:15137\u201315142. https:\/\/doi.org\/10.1073\/PNAS.96.26.15137","journal-title":"Proc Natl Acad Sci"},{"key":"11467_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ANA.20708","volume":"59","author":"HJT Ward","year":"2006","unstructured":"Ward HJT, Everington D, Cousens SN et al (2006) Risk factors for variant Creutzfeldt-Jakob disease: a case\u2013control study. Ann Neurol 59:111\u2013120. https:\/\/doi.org\/10.1002\/ANA.20708","journal-title":"Ann Neurol"},{"key":"11467_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","volume":"17","author":"N Watson","year":"2021","unstructured":"Watson N, Brandel J-P, Green A et al (2021) The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 17:362\u2013379. https:\/\/doi.org\/10.1038\/s41582-021-00488-7 (17:6)","journal-title":"Nat Rev Neurol"},{"key":"11467_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0B013E31821A4439","volume":"76","author":"P Vitali","year":"2011","unstructured":"Vitali P, MacCagnano E, Caverzasi E et al (2011) Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711\u20131719. https:\/\/doi.org\/10.1212\/WNL.0B013E31821A4439","journal-title":"Neurology"},{"key":"11467_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/PRACTNEUROL-2018-001935","volume":"19","author":"AJE Green","year":"2019","unstructured":"Green AJE (2019) RT-QuIC: a new test for sporadic CJD. Pract Neurol 19:49\u201355. https:\/\/doi.org\/10.1136\/PRACTNEUROL-2018-001935","journal-title":"Pract Neurol"},{"key":"11467_CR10","first-page":"211","volume":"21","author":"M Corato","year":"2006","unstructured":"Corato M, Cereda C, Cova E et al (2006) Young-onset CJD: Age and disease phenotype in variant and sporadic forms. Funct Neurol 21:211\u2013215","journal-title":"Funct Neurol"},{"key":"11467_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ANA.20568","volume":"58","author":"C Boesenberg","year":"2005","unstructured":"Boesenberg C, Schulz-Schaeffer WJ, Meissner B et al (2005) Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol 58:533\u2013543. https:\/\/doi.org\/10.1002\/ANA.20568","journal-title":"Ann Neurol"},{"key":"11467_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/19336896.2017.1287656","volume":"11","author":"Q Shi","year":"2017","unstructured":"Shi Q, Xiao K, Chen C et al (2017) Clinical and laboratory features of 14 young Chinese probable sCJD patients. Prion 11:128. https:\/\/doi.org\/10.1080\/19336896.2017.1287656","journal-title":"Prion"},{"key":"11467_CR13","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1080\/19336896.2016.1162644","volume":"10","author":"RA Maddox","year":"2016","unstructured":"Maddox RA, Person MK, Schonberger LB et al (2016) Unusually young prion disease cases in the United States, 1979\u20132014. Prion 10:S37\u2013S127. https:\/\/doi.org\/10.1080\/19336896.2016.1162644","journal-title":"Prion"},{"key":"11467_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/S13256-019-2089-5","author":"D Lahiri","year":"2019","unstructured":"Lahiri D, Pattnaik S, Bhat A et al (2019) Young-onset sporadic Creutzfeldt-Jakob disease with atypical phenotypic features: a case report. J Med Case Rep. https:\/\/doi.org\/10.1186\/S13256-019-2089-5","journal-title":"J Med Case Rep"},{"key":"11467_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012737.10.1212\/WNL.0000000000012737","author":"BS Appleby","year":"2021","unstructured":"Appleby BS, Maddox R, Schonberger LB et al (2021) Sporadic Creutzfeldt-Jakob disease in a very young person. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012737.10.1212\/WNL.0000000000012737","journal-title":"Neurology"},{"key":"11467_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.104570","author":"K Murray","year":"2008","unstructured":"Murray K, Ritchie DL, Bruce M et al (2008) Sporadic Creutzfeldt Jakob disease in two adolescents. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.2006.104570","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11467_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF00143129","volume":"7","author":"J Kulczycki","year":"1991","unstructured":"Kulczycki J, Jedrzejowska H, Gajkowski K et al (1991) Creutzfeldt-Jakob disease in young people. Eur J Epidemiol 7:501\u2013504. https:\/\/doi.org\/10.1007\/BF00143129","journal-title":"Eur J Epidemiol"},{"key":"11467_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"The Lancet"},{"key":"11467_CR19","unstructured":"National CJD Research & Surveillance Unit (2017) Protocol for Surveillance of CJD in the UK"},{"key":"11467_CR20","unstructured":"Creutzfeldt-Jakob Disease International Surveillance Network Diagnostic criteria for surveillance of CJD from 1 January 2017. In: 2017. https:\/\/www.eurocjd.ed.ac.uk\/node\/833. Accessed 8 Dec 2021"},{"key":"11467_CR21","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/BRAIN\/AWP191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659. https:\/\/doi.org\/10.1093\/BRAIN\/AWP191","journal-title":"Brain"},{"key":"11467_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNS.2020.117221","author":"N Watson","year":"2021","unstructured":"Watson N, Kurudzhu H, Green A et al (2021) Application of telehealth for comprehensive Creutzfeldt-Jakob disease surveillance in the United Kingdom. J Neurol Sci. https:\/\/doi.org\/10.1016\/J.JNS.2020.117221","journal-title":"J Neurol Sci"},{"key":"11467_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ANA.20261","volume":"56","author":"BJ Steinhoff","year":"2004","unstructured":"Steinhoff BJ, Zerr I, Glatting M et al (2004) Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 56:702\u2013708. https:\/\/doi.org\/10.1002\/ANA.20261","journal-title":"Ann Neurol"},{"key":"11467_CR24","doi-asserted-by":"publisher","unstructured":"Parchi P, Giese A, Capellari S, et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. https:\/\/doi.org\/10.1002\/1531-8249(199908)46:2","DOI":"10.1002\/1531-8249(199908)46:2"},{"key":"11467_CR25","unstructured":"The National CJD Research & Surveillance Unit (2020) 29th Annual Report 2020\u2014Creutzfeldt-Jakob Disease Surveillance in the UK"},{"key":"11467_CR26","unstructured":"R Core Team (2021) R: A language and environment for statistical computing"},{"key":"11467_CR27","unstructured":"Therneau T (2021) A Package for Survival Analysis in R"},{"key":"11467_CR28","unstructured":"Kassambara A, Kosinski M, Biecek P (2021) survminer: Drawing Survival Curves using \u201cggplot2\u201d"},{"key":"11467_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJMC1610003","volume":"376","author":"T Mok","year":"2017","unstructured":"Mok T, Jaunmuktane Z, Joiner S et al (2017) Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP CODON 129. N Engl J Med 376:292\u2013294. https:\/\/doi.org\/10.1056\/NEJMC1610003","journal-title":"N Engl J Med"},{"key":"11467_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/JNP.2007.19.4.428","volume":"19","author":"BS Appleby","year":"2007","unstructured":"Appleby BS, Appleby KK, Rabins Pv (2007) Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years. J Neuropsychiatry Clin Neurosci 19:428\u2013435. https:\/\/doi.org\/10.1176\/JNP.2007.19.4.428","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"11467_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23:34. https:\/\/doi.org\/10.1186\/s10194-022-01402-2","journal-title":"J Headache Pain"},{"key":"11467_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1212\/01.wnl.0000184674.32924.c9","volume":"65","author":"B Meissner","year":"2005","unstructured":"Meissner B, Westner IM, Kallenberg K et al (2005) Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 65:1544\u20131550. https:\/\/doi.org\/10.1212\/01.wnl.0000184674.32924.c9","journal-title":"Neurology"},{"key":"11467_CR33","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari M (2004) Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127:2348\u20132359. https:\/\/doi.org\/10.1093\/brain\/awh249","journal-title":"Brain"},{"key":"11467_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062553","volume":"8","author":"C Chen","year":"2013","unstructured":"Chen C, Wang J-C, Shi Q et al (2013) Analyses of the survival time and the influencing factors of chinese patients with prion diseases based on the surveillance data from 2008\u20132011. PLoS ONE 8:e62553. https:\/\/doi.org\/10.1371\/journal.pone.0062553","journal-title":"PLoS ONE"},{"key":"11467_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2188\/jea.JE20100085","volume":"21","author":"K Nagoshi","year":"2011","unstructured":"Nagoshi K, Sadakane A, Nakamura Y et al (2011) Duration of prion disease is longer in Japan than in other countries. J Epidemiol 21:255\u2013262. https:\/\/doi.org\/10.2188\/jea.JE20100085","journal-title":"J Epidemiol"},{"key":"11467_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, S\u00e1nchez-Valle R, Green A et al (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254:901. https:\/\/doi.org\/10.1007\/s00415-006-0472-9","journal-title":"J Neurol"},{"key":"11467_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637\u2013643. https:\/\/doi.org\/10.1212\/01.wnl.0000230159.67128.00","journal-title":"Neurology"},{"key":"11467_CR38","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","volume":"95","author":"DD Rhoads","year":"2020","unstructured":"Rhoads DD, Wrona A, Foutz A et al (2020) Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology 95:e1017\u2013e1026. https:\/\/doi.org\/10.1212\/WNL.0000000000010086","journal-title":"Neurology"},{"key":"11467_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ANA.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orr\u00fa CD et al (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 72:278\u2013285. https:\/\/doi.org\/10.1002\/ANA.23589","journal-title":"Ann Neurol"},{"key":"11467_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18700\/JNC.190079","volume":"12","author":"JA Hartshorn","year":"2019","unstructured":"Hartshorn JA, Foreman B (2019) Generalized periodic discharges with triphasic morphology. J Neurocrit Care 12:1\u20138. https:\/\/doi.org\/10.18700\/JNC.190079","journal-title":"J Neurocrit Care"},{"key":"11467_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/S40249-016-0143-8","author":"C Chen","year":"2016","unstructured":"Chen C, Dong XP (2016) Epidemiological characteristics of human prion diseases. Infect Dis Poverty. https:\/\/doi.org\/10.1186\/S40249-016-0143-8","journal-title":"Infect Dis Poverty"},{"key":"11467_CR42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/BRAIN\/AWG125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S, Wadsworth JDF et al (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333\u20131346. https:\/\/doi.org\/10.1093\/BRAIN\/AWG125","journal-title":"Brain"},{"key":"11467_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/ANA.21987","volume":"67","author":"CA Heath","year":"2010","unstructured":"Heath CA, Cooper SA, Murray K et al (2010) Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 67:761\u2013770. https:\/\/doi.org\/10.1002\/ANA.21987","journal-title":"Ann Neurol"},{"key":"11467_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","volume":"14","author":"S Mead","year":"2006","unstructured":"Mead S (2006) Prion disease genetics. Eur J Hum Genet 14:273\u2013281. https:\/\/doi.org\/10.1038\/sj.ejhg.5201544 (14:3)","journal-title":"Eur J Hum Genet"},{"key":"11467_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","volume":"17","author":"S Mead","year":"2017","unstructured":"Mead S, Rudge P (2017) CJD mimics and chameleons. Pract Neurol 17:113. https:\/\/doi.org\/10.1136\/practneurol-2016-001571","journal-title":"Pract Neurol"},{"key":"11467_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1474-4422(22)00082-5","volume":"21","author":"S Mead","year":"2022","unstructured":"Mead S, Khalili-Shirazi A, Potter C et al (2022) Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme. Lancet Neurol 21:342\u2013354. https:\/\/doi.org\/10.1016\/S1474-4422(22)00082-5","journal-title":"Lancet Neurol"},{"key":"11467_CR47","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/BRAIN\/AWT048","volume":"136","author":"AGB Thompson","year":"2013","unstructured":"Thompson AGB, Lowe J, Fox Z et al (2013) The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain 136:1116\u20131127. https:\/\/doi.org\/10.1093\/BRAIN\/AWT048","journal-title":"Brain"},{"key":"11467_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/JNNP-2021-327722","author":"A Nihat","year":"2022","unstructured":"Nihat A, Mok TH, Odd H et al (2022) Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/JNNP-2021-327722","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11467-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:15:54Z","timestamp":1675055754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11467-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["11467"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11467-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}